Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NSCLC
Sort By
Newest First
1 / 1
Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04
Feb 07, 2022
Cancer and Neurodegenerative Diseases
Leveraging the Cell Cytoskeleton for the Treatment of Cancer and Neurodegenerative Diseases
Maurice Zauderer, Ph.D.
Vaccinex, Inc.
PAP-Q2-20-CL-024
Jul 01, 2020
1 / 1
